Who owns ATEA PHARMACEUTICALS INC?
- Ticker: AVIR
- CUSIP Number: 04683r106
Tip: Access positions for across all investors
Analyze quarterly positions in Atea Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Atea Pharmaceuticals stock
Who bought or sold ATEA PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
EcoR1 Capital | 7.0M | $21M | 0% | Dec 2023 |
|
BML Capital Management | 5.5M | $22M | 1% | Mar 2024 |
|
Vanguard Group | 4.6M | $14M | 1% | Dec 2023 |
|
Tang Capital Management | 4.1M | $12M | 13% | Dec 2023 |
|
Federated Investors | 596k | $1.8M | -2% | Dec 2023 |
|
Charles Schwab Investment Management | 584k | $1.8M | 0% | Dec 2023 |
|
Jacobs Levy Equity Management | 551k | $1.7M | -1% | Dec 2023 |
|
Newtyn Management | 509k | $1.6M | 27% | Dec 2023 |
|
Banque Pictet & Cie Sa | 345k | $1.1M | 0% | Dec 2023 |
|
Two Sigma Advisers | 319k | $973k | 55% | Dec 2023 |
|
CM Management | 270k | $824k | -2% | Dec 2023 |
|
Bank of America Corporation | 244k | $743k | 153% | Dec 2023 |
|
Bank of New York Mellon | 240k | $968k | -6% | Mar 2024 |
|
Goldman Sachs Group | 229k | $698k | -12% | Dec 2023 |
|
Barclays | 197k | $601k | 669% | Dec 2023 |
|
Citadel Advisors | 190k | $579k | -69% | Dec 2023 |
|
D. E. Shaw & Co | 185k | $565k | 165% | Dec 2023 |
|
Hsbc Holdings | 180k | $554k | 1391% | Dec 2023 |
|
Cubist Systematic Strategies | 178k | $544k | 28% | Dec 2023 |
|
Auour Investments | 177k | $715k | 0% | Mar 2024 |
|
Acuitas Investments | 171k | $615k | 39% | Dec 2023 |
|
Two Sigma Investments | 162k | $494k | 199% | Dec 2023 |
|
GSA Capital Partners | 150k | $457k | -46% | Dec 2023 |
|
Rhumbline Advisers | 147k | $449k | 10% | Dec 2023 |
|
State of Wisconsin Investment Board | 130k | $396k | 5% | Dec 2023 |
|
Alliancebernstein | 121k | $368k | -3% | Dec 2023 |
|
Simplex Trading | 117k | $471k | 767% | Mar 2024 |
|
UBS Group | 108k | $328k | 89% | Dec 2023 |
|
New York Life Investment Management | 103k | $314k | -3% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 101k | $307k | 0% | Dec 2023 |
|
CSS | 93k | $283k | 11% | Dec 2023 |
|
Dimensional Fund Advisors | 92k | $282k | 0% | Dec 2023 |
|
Jane Street | 79k | $240k | 432% | Dec 2023 |
|
Jpmorgan Chase & Co | 68k | $209k | 0% | Dec 2023 |
|
ALPS Advisors | 58k | $178k | -5% | Dec 2023 |
|
T. Rowe Price Associates | 55k | $169k | 31% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 52k | $159k | -43% | Dec 2023 |
|
Shay Capital | 50k | $153k | 3% | Dec 2023 |
|
MetLife Investment Advisors | 47k | $144k | 0% | Dec 2023 |
|
Marquette Asset Management | 47k | $144k | 90% | Dec 2023 |
|
SG Americas Securities | 43k | $130k | 23% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 39k | $117k | -5% | Dec 2023 |
|
American International | 38k | $116k | 0% | Dec 2023 |
|
Algert Coldiron Investors | 37k | $113k | -27% | Dec 2023 |
|
Norges Bank Investment Management | 36k | $110k | 100% | Dec 2023 |
|
Mirae Asset Global Investments | 31k | $123k | 100% | Mar 2024 |
|
Royal Bank of Canada | 30k | $91k | 111% | Dec 2023 |
|
Brevan Howard Capital Management | 26k | $78k | 100% | Dec 2023 |
|
Principal Financial Group | 25k | $103k | -8% | Mar 2024 |
|
Wells Fargo & Company | 24k | $73k | 24% | Dec 2023 |
|
Florida State Board of Administration | 22k | $67k | 0% | Dec 2023 |
|
Ohio Pers | 18k | $55k | 0% | Dec 2023 |
|
New York State Common Retirement Fund | 16k | $50k | -1% | Dec 2023 |
|
China Universal Asset Management | 16k | $65k | 68% | Mar 2024 |
|
Millennium Management | 16k | $48k | -64% | Dec 2023 |
|
Wolverine Trading | 14k | $42k | 100% | Dec 2023 |
|
Point72 Middle East FZE | 13k | $40k | 496% | Dec 2023 |
|
Rpo | 13k | $40k | 100% | Dec 2023 |
|
Citigroup | 13k | $38k | 1062% | Dec 2023 |
|
Sunpointe | 12k | $48k | 0% | Mar 2024 |
|
Graham Capital Management | 11k | $35k | 100% | Dec 2023 |
|
Ronald Blue Trust | 8.7k | $35k | 0% | Mar 2024 |
|
Summit Investment Advisors | 7.5k | $23k | 48% | Dec 2023 |
|
Advisor Group Holdings | 7.3k | $22k | -20% | Dec 2023 |
|
Legal & General Group | 6.0k | $18k | 0% | Dec 2023 |
|
Russell Investments | 4.9k | $15k | 5% | Dec 2023 |
|
Amalgamated Bank | 2.7k | $11k | -61% | Mar 2024 |
|
Metropolitan Life Insurance Company | 2.2k | $6.7k | -52% | Dec 2023 |
|
Capital Advisors | 1.6k | $7.0k | 100% | Mar 2024 |
|
Daiwa Securities Group | 242.00 | $999.992400 | 0% | Mar 2024 |
|
Farther Finance Advisors | 216.00 | $658.994400 | 57% | Dec 2023 |
|
O'Dell Group | 200.00 | $610.000000 | 100% | Dec 2023 |
|
Frazier Financial Advisors | 120.00 | $366.000000 | 100% | Dec 2023 |
|
Pnc Financial Services | 74.00 | $226.003400 | 100% | Dec 2023 |
|
LM Advisors | 50.00 | $153.000000 | 100% | Dec 2023 |
|
NISA Investment Advisors | 23.00 | $93.000500 | 0% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 15.00 | $60.000000 | 100% | Mar 2024 |
|
Who sold out of Atea Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Vontobel Holding | Sep 2023 | 601k | $1.8M |
Hrt Financial | Sep 2023 | 71k | $213k |
Squarepoint Ops | Sep 2023 | 41k | $124k |
AQR Capital Management | Sep 2023 | 30k | $91k |
Virtus ETF Advisers | Sep 2023 | 24k | $73k |
Pinnacle Wealth Planning Services | Sep 2023 | 16k | $49k |
William Blair $ Company | Sep 2023 | 10k | $31k |
Gladius Capital Management | Sep 2023 | 8.6k | $26k |
Lazard Asset Management | Sep 2023 | 2.3k | $6.0k |
SCBT Financial Corporation | Sep 2023 | 565.00 | $1.7k |